MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/02698811241286773

Медицинская библиотека · Journal of psychopharmacology (Oxford, England) · 2024

Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study.

Lukow Paulina B, Lowther Millie, Pike Alexandra C, Yamamori Yumeya, Chavanne Alice V, Gormley Siobhan, Aylward Jessica, McCloud Tayla, Goble Talya, Rodriguez-Sanchez Julia, Tuominen Ella W, Buehler Sarah K, Kirk Peter, Robinson Oliver J

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Selective serotonin reuptake inhibitors (SSRIs) are used for the treatment of several conditions including anxiety disorders, but the basic neurobiology of serotonin function remains unclear. The amygdala and prefrontal cortex are strongly innervated by serotonergic projections and have been suggested to play an important role in anxiety expression. However, serotonergic function in behaviour and SSRI-mediated neurobiological changes remain incompletely understood.

AIMS: To investigate the neural correlates of subchronic antidepressant administration.

METHODS

We investigated whether the 2- to 3-week administration of a highly selective SSRI (escitalopram) would alter brain activation on a task robustly shown to recruit the bilateral amygdala and frontal cortices in a large healthy volunteer sample. Participants performed the task during a functional magnetic resonance imaging acquisition before (n = 96) and after subchronic escitalopram (n = 46, days of administration mean (SD) = 15.7 (2.70)) or placebo (n = 40 days of administration mean (SD) = 16.2 (2.90)) self-administration.

RESULTS

Compared to placebo, we found an elevation in right amygdala activation to the task after escitalopram administration without significant changes in mood. This effect was not seen in the left amygdala, the dorsomedial region of interest, the subgenual anterior cingulate cortex or the right fusiform area. There were no significant changes in connectivity between the dorsomedial cortex and amygdala or the subgenual anterior cingulate cortex after escitalopram administration.

CONCLUSIONS

To date, this most highly powered study of subchronic SSRI administration indicates that, contrary to effects often seen in patients with anxiety disorders, subchronic SSRI treatment may increase amygdala activation in healthy controls. This finding highlights important gaps in our understanding of the functional role of serotonin.

Для цитирования: Lukow Paulina B, Lowther Millie, Pike Alexandra C, Yamamori Yumeya, Chavanne Alice V, Gormley Siobhan, Aylward Jessica, McCloud Tayla, Goble Talya, Rodriguez-Sanchez Julia, Tuominen Ella W, Buehler Sarah K, Kirk Peter, Robinson Oliver J. Amygdala activity after subchronic escitalopram administration in healthy volunteers: A pharmaco-functional magnetic resonance imaging study.. Journal of psychopharmacology (Oxford, England). 2024. DOI: 10.1177/02698811241286773.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.